HomeMy WebLinkAbout7.22.22 Board Correspondence - FW_ OLUMIANT (baricitanib)
From:Paulsen, Shaina
To:Pickett, Andy; Valencia, Shyanne; Reaster, Kayla
Cc:Nuzum, Danielle
Subject:Board Correspondence - FW: OLUMIANT (baricitanib)
Date:Friday, July 22, 2022 8:13:57 AM
This went to the full Board.
Shaina Paulsen
Associate Clerk of The Board
Butte County Administration
25 County Center Drive, Suite 200, Oroville, CA 95965
T: 530.552.3304 | F: 530.538.7120
From: Julie Threet <ladythreet@gmail.com>
Sent: Friday, July 22, 2022 8:12 AM
To: York, Danette <DYork@buttecounty.net>; lalmaguer@buttecounty.edu;
dcanton@buttecounty.org; lalmaguer@buttecounty.org
Cc: Ritter, Tami <TRitter@buttecounty.net>; Lucero, Debra <DLucero@buttecounty.net>;
Kimmelshue, Tod <TKimmelshue@buttecounty.net>; Connelly, Bill <BConnelly@buttecounty.net>;
Teeter, Doug <DTeeter@buttecounty.net>; Clerk of the Board <clerkoftheboard@buttecounty.net>;
Pickett, Andy <APickett@buttecounty.net>
Subject: OLUMIANT (baricitanib)
ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening
..
attachments, clicking on links, or replying.
Is this pharmaceutical that is under Emergency Use Authorization for COVID-19 here in
Butte County and is it being prescribed? OLUMIANT. Eli Lilly. I checked with you on
June 16 and it wasn't listed but I am hearing rumors. I hope you all do a really thorough job at
vetting these toxic potent drugs out and don't just take the CDC and NIH Fauci direction
because they have a horrific track record.
Remdesivir killed people at Enloe (people call me because they have no reliable place to go to
report these crimes). I have faith that eventually every victim of this authoritarian cabal will
find justice.
So, are there any other changes to what you confirmed last month?
- Bebtelovimab – Monoclonal antibodies
· Paxlovid (regular) - Antiviral
· Paxlovid (renal dosing) - Antiviral
· Molnupiravir - Antiviral
· Evusheld – Pre-exposure Prophylaxis (for immunocompromised patients)
DO NOT HAVE THESE AVAILABLE:
Casirivimab/imdevimab (REGEN-COV)
Sotrovimab
Remdesivir
Thank you.
Julie Threet